OREXIGEN THERAPEUTICS INC (OREX) Stock Price, Quote, News and Overview
NASDAQ:OREX - Nasdaq - US6861643020
OREX Quote, Performance and Key Statistics
0.223
-0.12 (-34.41%)
The current stock price of OREX is 0.223 null. In the past month the price decreased by -82.44%. In the past year, price decreased by -91.58%.
About OREX
Company Profile
OREXIGEN THERAPEUTICS, INC. is a biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of central nervous system disorders, including obesity. The Company's lead combination product candidates targeted for obesity are Contrave, which is in Phase III clinical trials, and Empatic, which is in the later stages of Phase II clinical development. Both product candidates are designed to take advantage of the Company's understanding of how the brain appears to regulate appetite and energy expenditure, as well as the mechanisms that come into play to limit weight loss over time. Each product candidate is designed to act on a specific group of neurons in the central nervous system with the goal of achieving appetite suppression and sustained weight loss.
Company Info
OREXIGEN THERAPEUTICS INC
3344 N. TORREY PINES CT. SUITE 200
LA JOLLA CA 92037
CEO: Michael A. Narachi
Phone: 858-875-8600
OREXIGEN THERAPEUTICS INC / OREX FAQ
What is the stock price of OREXIGEN THERAPEUTICS INC today?
The current stock price of OREX is 0.223 null. The price decreased by -34.41% in the last trading session.
What is the ticker symbol for OREXIGEN THERAPEUTICS INC stock?
The exchange symbol of OREXIGEN THERAPEUTICS INC is OREX and it is listed on the Nasdaq exchange.
On which exchange is OREX stock listed?
OREX stock is listed on the Nasdaq exchange.
What is OREXIGEN THERAPEUTICS INC worth?
OREXIGEN THERAPEUTICS INC (OREX) has a market capitalization of 4.21M null. This makes OREX a Nano Cap stock.
Should I buy OREXIGEN THERAPEUTICS INC (OREX) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of OREX, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of OREX, evaluating the profitability, health, valuation and growth aspects
- OREXIGEN THERAPEUTICS INC (OREX) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- OREXIGEN THERAPEUTICS INC (OREX) Sales and EPS estimates to see what analysts future expectations are.
- OREXIGEN THERAPEUTICS INC (OREX) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- OREXIGEN THERAPEUTICS INC (OREX) Insider and Institutional Ownership to learn about the owners and their transactions.
- OREXIGEN THERAPEUTICS INC (OREX) Stock Chart to make your own analysis
- OREXIGEN THERAPEUTICS INC (OREX) Latest news and press-releases to stay up to date.
Does OREXIGEN THERAPEUTICS INC (OREX) stock pay dividends?
OREX does not pay a dividend.
What is the Price/Earnings (PE) ratio of OREXIGEN THERAPEUTICS INC (OREX)?
OREXIGEN THERAPEUTICS INC (OREX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-7.73).
OREX Technical Analysis
OREX Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to OREX. OREX may be in some trouble as it scores bad on both profitability and health.
OREX Financial Highlights
Over the last trailing twelve months OREX reported a non-GAAP Earnings per Share(EPS) of -7.734800000000001. The EPS decreased by -145.04% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -192.65% | ||
| ROA | -78.94% | ||
| ROE | 245.74% | ||
| Debt/Equity | -0.43 |